78 related articles for article (PubMed ID: 38609650)
1. Validation of the Absorption-Enhancing Ability of Oligoarginines Grafted onto a Backbone of Hyaluronic Acid through Animal Studies from Rodents to Primates.
Yagi H; Tomono T; Abe K; Tsutsumi Y; Makabe M; Mitsuhashi H; Kimura T; Kobayashi H; Miyata K; Shigeno K; Sakuma S
Mol Pharm; 2024 May; ():. PubMed ID: 38804275
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and meta-analysis of deferiprone monotherapy and in combination with deferoxamine for reduction of iron overload in chronically transfused patients with β-thalassemia.
Kuo KH; Mrkobrada M
Hemoglobin; 2014; 38(6):409-21. PubMed ID: 25307964
[TBL] [Abstract][Full Text] [Related]
3. Bile Acid-Targeted Hyaluronic Acid Nanoparticles for Enhanced Oral Absorption of Deferoxamine.
Agboluaje EO; Cui S; Grimsey NJ; Xiong MP
AAPS J; 2024 Apr; 26(3):46. PubMed ID: 38609650
[TBL] [Abstract][Full Text] [Related]
4. Enzymatically Biodegradable Polyrotaxane-Deferoxamine Conjugates for Iron Chelation.
Liu Z; Lin TM; Purro M; Xiong MP
ACS Appl Mater Interfaces; 2016 Oct; 8(39):25788-25797. PubMed ID: 27623539
[TBL] [Abstract][Full Text] [Related]
5. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
[TBL] [Abstract][Full Text] [Related]
6. Oral Non-absorbable Polymer-Deferoxamine Conjugates for Reducing Dietary Iron Absorption.
Cui S; Liu Z; Nagy T; Agboluaje EO; Xiong MP
Mol Pharm; 2023 Feb; 20(2):1285-1295. PubMed ID: 36622899
[TBL] [Abstract][Full Text] [Related]
7. Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.
Farr AC; Xiong MP
Mol Pharm; 2021 Feb; 18(2):593-609. PubMed ID: 32926630
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tissue distribution of deferoxamine-based nanochelator in rats.
Jones G; Zeng L; Stiles WR; Park SH; Kang H; Choi HS; Kim J
Nanomedicine (Lond); 2022 Sep; 17(22):1649-1662. PubMed ID: 36547231
[TBL] [Abstract][Full Text] [Related]
9. The world's first CRISPR therapy is approved: who will receive it?
Sheridan C
Nat Biotechnol; 2024 Jan; 42(1):3-4. PubMed ID: 37989785
[No Abstract] [Full Text] [Related]
10. Double layer spherical nanoparticles with hyaluronic acid coating to enhance oral delivery of exenatide in T2DM rats.
Lu Y; Wu L; Lin M; Bao X; Zhong H; Ke P; Dai Q; Yang Q; Tang X; Xu W; Xu D; Han M
Eur J Pharm Biopharm; 2023 Oct; 191():205-218. PubMed ID: 37683898
[TBL] [Abstract][Full Text] [Related]
11. pH-Responsive and Mucoadhesive Nanoparticles for Enhanced Oral Insulin Delivery: The Effect of Hyaluronic Acid with Different Molecular Weights.
Wang S; Meng S; Zhou X; Gao Z; Piao MG
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986680
[TBL] [Abstract][Full Text] [Related]
12. Sickle cell disease is a global prototype for integrative research and healthcare.
Royal CDM; Babyak M; Shah N; Srivatsa S; Stewart KA; Tanabe P; Wonkam A; Asnani M
Adv Genet (Hoboken); 2021 Mar; 2(1):e10037. PubMed ID: 36618444
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B infection among β-thalassemia major patients in Bushehr province of southern Iran.
Farshadpour F; Taherkhani R; Farajzadeh H
J Immunoassay Immunochem; 2023 Mar; 44(2):147-161. PubMed ID: 36587831
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic Acid: A Review of the Drug Delivery Capabilities of This Naturally Occurring Polysaccharide.
Buckley C; Murphy EJ; Montgomery TR; Major I
Polymers (Basel); 2022 Aug; 14(17):. PubMed ID: 36080515
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
